Page 275«..1020..274275276277..280290..»

Harvesting stem cells from horse bone marrow at UT

By Dr. Matthew Watson

Staff at the University of Tennessee Veterinary Medical Center demonstrate how they harvest allogenic stem cells from horse bone marrow.

Follow this link:
Harvesting stem cells from horse bone marrow at UT

To Read More: Harvesting stem cells from horse bone marrow at UT
categoriaBone Marrow Stem Cells commentoComments Off on Harvesting stem cells from horse bone marrow at UT | dataOctober 12th, 2011
Read All

Chocolate compounds fight high cholesterol

By Dr. Matthew Watson

Chocolate has received a lot of attention for being a treasure trove of nutritional goodness. Polyphenols in cacao beans are linked to promoting heart, brain, and liver health, which has sparked renewed interest in chocolate as a medicinal food. And a new study adds to the growing list of benefits, showing that chocolate polyphenols also help to lower bad cholesterol.

Published in the journal Diabetic Medicine, the study tested the effects of polyphenol-rich chocolate in a group of 12 volunteers with type-2 diabetes. After 16 weeks, the researchers from Hull University in the U.K. discovered that the polyphenols helped lower participants' bad cholesterol levels while raising good cholesterol levels.

"Chocolate with a high cocoa content should be included in the diet of individuals with type-2 diabetes as part of a sensible, balanced approach to diet and lifestyle," said professor Steve Akin, author of the study. Read more...

Immunice for Immune Support

Source:
http://feeds.feedburner.com/integratedmedicine

To Read More: Chocolate compounds fight high cholesterol
categoriaIntegrative Medicine commentoComments Off on Chocolate compounds fight high cholesterol | dataOctober 9th, 2011
Read All

International Stem Cell Corp. Chairman Kenneth Aldrich Comments on Recent TIME Article “A Stem Cell First: Using the ‘Dolly’ Method on Human Cells”

By Dr. Matthew Watson

“Since we at International Stem Cell Corporation (trading symbol: ISCO.OB) are licensees of some of the key intellectual property necessary to use SCNT in therapeutic products, we were delighted to read about this new discovery.  However, what disappointed us somewhat was the failure of most news reports to mention that a technology already exists that solves the same ethical problems and has the potential also to solve many of the problems of immune rejection that worry scientists who are working with cells obtained from fertilized embryos.
That technology is called "Parthenogenesis" and results in a "cell line" that can provide an essentially unlimited supply of human cells for a wide range of therapeutic purposes, yet does not involve the destruction of any fertilized embryo and results in cells that can be matched to large groups of people who may not even know the patient, much like the way blood from donors can be stored and used by accident victims as needed. Unlike the SCNT cells, parthenogenetic cells require no genetic manipulation or insertion of foreign DNA.
Our scientists at ISCO created and patented the process for making such human parthenogenetic stem cell lines and have already successfully made liver cells, cornea cells, retina cells and nerve cells from those cell lines.  Each of these applications is being studied as a possible future source of transplanted cells to treat diseases such as Parkinson's, Liver Disease, Macular Degeneration, and others. 
To learn more about parthenogenesis, visit our website at http://www.internationalstemcell.com or click on ISCO.OB at any financial web site for information about our company.”
Kenneth C. Aldrich
Chairman
International Stem Cell Corporation
TIME Article – A Stem Cell First: Using the 'Dolly' Method on Human Cells
About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.
To subscribe to receive ongoing corporate communications, please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0 .
Forward-looking Statements
Statements pertaining to anticipated developments, and other opportunities for the company and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates,") should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products and the management of collaborations, regulatory approvals, need and ability to obtain future capital, application of capital resources among competing uses, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the company's business, particularly those mentioned in the cautionary statements found in the company's Securities and Exchange Commission filings. The company disclaims any intent or obligation to update forward-looking statements.

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

To Read More: International Stem Cell Corp. Chairman Kenneth Aldrich Comments on Recent TIME Article “A Stem Cell First: Using the ‘Dolly’ Method on Human Cells”
categoriaStem Cell Therapy commentoComments Off on International Stem Cell Corp. Chairman Kenneth Aldrich Comments on Recent TIME Article “A Stem Cell First: Using the ‘Dolly’ Method on Human Cells” | dataOctober 9th, 2011
Read All

International Stem Cell Names Dr. Andrey Semechkin as Co-Chairman and Kurt May as President and Chief Operating Officer

By Dr. Matthew Watson

International Stem Cell Corporation (OTCBB:ISCO) today announced that its Board of Directors designated Dr. Andrey Semechkin, the Company's Chief Executive Officer, as a Co-Chairman with the Company's founder, Kenneth Aldrich, and also named Kurt May as President and Chief Operating Officer, effective immediately. Mr. May is currently Senior Vice President and this represents both a promotion and the delegation of additional duties and responsibilities consistent with his increasingly important role in the future of ISCO.
Dr. Semechkin commented, "Kurt May is an extremely capable executive who has managed both a multi-billion dollar public company and a successful life sciences startup company. His willingness to assume operational responsibilities for ISCO will allow me, as CEO, to focus more intently on scientific and strategic initiatives that are central to developing ISCO into a major force in the world of stem cell therapy. Working together with the fine team of executives and scientists already within ISCO, I have high hopes and confidence we can reach that goal."
Prior to joining ISCO, Mr. May was a senior executive with GTE Corporation and with PriceSmart, Inc., and the founder and CEO of a privately owned biotech company, Psynomics, based on medical technology derived from the University of California, San Diego. Mr. May served as a faculty member and Assistant Dean of UCSD's Rady School of Management from 2005 to 2009.
During his tenure as PriceSmart's Chief Operating Officer, Mr. May led the company from startup to growth over three years that included establishing 22 stores in 11 countries, reaching annual revenues of more than $500 million, achieving profitability, and expanding staff from 356 to more than 4,200.

"In addition to its therapeutic programs, ISCO is dedicated to building its revenue-generating subsidiaries to high levels of profitability. We view Mr. May's commercial and entrepreneurial skills as an essential part of our business plan for success," said Kenneth Aldrich, Co-Founder and Co-Chairman of ISCO.
About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.
To subscribe to receive ongoing corporate communications, please click on the following link:http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.
Forward-looking Statements
Statements pertaining to anticipated developments, and other opportunities for the company and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates,") should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products and the management of collaborations, regulatory approvals, need and ability to obtain future capital, application of capital resources among competing uses, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the company's business, particularly those mentioned in the cautionary statements found in the company's Securities and Exchange Commission filings. The company disclaims any intent or obligation to update forward-looking statements.
http://cts.businesswire.com/ct/CT?id=bwnews&sty=20111006005285r1&sid=14230&distro=ftp
International Stem Cell Corporation

Kenneth C. Aldrich, Co-Chairman
760-940-6383
kaldrich@intlstemcell.com
or
Lippert/Heilshorn & Associates
Don Markley, 310-691-7100
dmarkley@lhai.com

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

To Read More: International Stem Cell Names Dr. Andrey Semechkin as Co-Chairman and Kurt May as President and Chief Operating Officer
categoriaStem Cell Therapy commentoComments Off on International Stem Cell Names Dr. Andrey Semechkin as Co-Chairman and Kurt May as President and Chief Operating Officer | dataOctober 9th, 2011
Read All

Mesenchymal stem cells and marrow stromal cells—2nd—

By Dr. Matthew Watson

Marrow stromal cells The existence of nonhematopoietic cells in bone marrow was first suggested by Cohnheim about 130 years ago [16]. To date, marrow stromal cells have been shown to differentiate into osteoblasts [17], chondrocytes [18], skeletal myocytes, adipocytes, and cardiomyocytes [19] in vitro, and thus are a useful cell source for regenerative medicine [20, 21]. Recent studies suggest that bone marrow stromal cells can also differentiate into a neuronal lineage [14], and murine bone marrow derived multipotent adult progenitor cell differentiate into dopaminergic neuronal cells [22].

Excerpt from:
Mesenchymal stem cells and marrow stromal cells---2nd---

To Read More: Mesenchymal stem cells and marrow stromal cells—2nd—
categoriaBone Marrow Stem Cells commentoComments Off on Mesenchymal stem cells and marrow stromal cells—2nd— | dataOctober 8th, 2011
Read All

Noah Stem Cell Transplant Day 3

By Dr. Matthew Watson

This is the 3rd day after Noah got a stem cell transplant for a back injury. Pause for Paws Rescue, San Antonio, TX

See the original post here:
Noah Stem Cell Transplant Day 3

To Read More: Noah Stem Cell Transplant Day 3
categoriaSpinal Cord Stem Cells commentoComments Off on Noah Stem Cell Transplant Day 3 | dataOctober 6th, 2011
Read All

Stem Cells extracted from bone marrow

By Dr. Matthew Watson

Details adult stem cells being extracted from human bone marrow via a syringe. Animation by Laura Lynn Gonzalez lauralynngonzalez.com

Excerpt from:
Stem Cells extracted from bone marrow

To Read More: Stem Cells extracted from bone marrow
categoriaBone Marrow Stem Cells commentoComments Off on Stem Cells extracted from bone marrow | dataOctober 6th, 2011
Read All

Dr.Thomas Barnes’ PRP Hair Growth and Skin Rejuvenation

By Dr. Matthew Watson

Newport Beach Cosmetic Surgeon, Dr. Thomas Barnes is an expert with PRP and stem cell therapies. Here he shows how PRP(Platelet Rich Plasma) is used to stimiulate hair growth which he calls Vampire Hair Growth because he uses your own bllod, removes the healing factors (PRP) and injects in the scalp or face skin for new scalp hair growth and of facial lines, pores and wrinkles rejuvenation.

Excerpt from:
Dr.Thomas Barnes' PRP Hair Growth and Skin Rejuvenation

To Read More: Dr.Thomas Barnes’ PRP Hair Growth and Skin Rejuvenation
categoriaSkin Stem Cells commentoComments Off on Dr.Thomas Barnes’ PRP Hair Growth and Skin Rejuvenation | dataOctober 5th, 2011
Read All

Regenerative Medicine and Applications of Stem Cell Research

By Dr. Matthew Watson

(June 1, 2010) Renee Reijo Pera, Ph.D., and Professor Michael Longaker discuss the future of regenerative medicine and the promise that stem cell research holds for this field. During the final quarter of the Stanford Mini Med School, some of the most timely and important topics in contemporary medicine and the biosciences are addressed. Stanford Mini Med School is a series arranged and directed by Stanford's School of Medicine and presented by the Stanford Continuing Studies program

Read this article:
Regenerative Medicine and Applications of Stem Cell Research

To Read More: Regenerative Medicine and Applications of Stem Cell Research
categoriaUncategorized commentoComments Off on Regenerative Medicine and Applications of Stem Cell Research | dataOctober 5th, 2011
Read All

StemCells Gains 5% on Neural Stem Cell Trial in Spinal Cord Injury

By Dr. Matthew Watson

Shares of StemCells (STEM) are up 5.85% after the company announced that it will initiate the Phase I/II clinical trial of its proprietary HuCNS-SC human neural stem cells in chronic spinal cord injury. The trial is now open for enrollment, and will accept patients with both complete and incomplete degrees of paralysis who are three to twelve months post-injury. It is being conducted in Switzerland at the Balgrist University Hospital, University of Zurich

See the rest here:
StemCells Gains 5% on Neural Stem Cell Trial in Spinal Cord Injury

To Read More: StemCells Gains 5% on Neural Stem Cell Trial in Spinal Cord Injury
categoriaSpinal Cord Stem Cells commentoComments Off on StemCells Gains 5% on Neural Stem Cell Trial in Spinal Cord Injury | dataOctober 5th, 2011
Read All

Bone Marrow Transplant and Stem Cell Transplant Treatment in India for International patients

By Dr. Matthew Watson

Leading Bone Marrow Transplant Specialist and doctor in India talks about bone marrow transplant or BMT, Stem Cell Transplant treatment for thalassemia, leukemia, sickle-cell disease and few other diseases in India for international patients looking for BMT or bone marrow transplant or stem cell transplant hospitals and doctors in India. Bone Marrow Transplant Package cost in India

Read more from the original source:
Bone Marrow Transplant and Stem Cell Transplant Treatment in India for International patients

To Read More: Bone Marrow Transplant and Stem Cell Transplant Treatment in India for International patients
categoriaBone Marrow Stem Cells commentoComments Off on Bone Marrow Transplant and Stem Cell Transplant Treatment in India for International patients | dataOctober 5th, 2011
Read All

How To Use Your Stem Cells For Facial Skin Rejuvenation

By Dr. Matthew Watson

facialskinrejuvenation.org Secrets

Read more from the original source:
How To Use Your Stem Cells For Facial Skin Rejuvenation

To Read More: How To Use Your Stem Cells For Facial Skin Rejuvenation
categoriaSkin Stem Cells commentoComments Off on How To Use Your Stem Cells For Facial Skin Rejuvenation | dataOctober 5th, 2011
Read All

Manning, Owens Try Stem Cell Therapy

By Dr. Matthew Watson

BY STEVEN HSIEH You're watching multisource sports video news analysis from Newsy. Two injured football stars -- flying overseas for experimental, stem cell therapy

See more here:
Manning, Owens Try Stem Cell Therapy

To Read More: Manning, Owens Try Stem Cell Therapy
categoriaIPS Cell Therapy commentoComments Off on Manning, Owens Try Stem Cell Therapy | dataOctober 5th, 2011
Read All

Adult Stem Cell Therapy for Multiple Sclerosis

By Dr. Matthew Watson

To Read More: Adult Stem Cell Therapy for Multiple Sclerosis
categoriaUncategorized commentoComments Off on Adult Stem Cell Therapy for Multiple Sclerosis | dataOctober 5th, 2011
Read All

Wikipedia Accurate on Cancer Facts, But Hard to Read: Study

By Dr. Matthew Watson

(HealthDay News) -- The facts about cancer found on the website Wikipedia are about as accurate as the information on the disease found on the patient-oriented section of the U.S. National Cancer Institute's Physician Data Query (PDQ), a comprehensive peer-reviewed cancer database, according to a new study.

Although experts from Thomas Jefferson University were hard-pressed to find errors on Wikipedia, they did find the content on the site was harder to read and included links to more dense information than the simplified, shorter explanations found on PDQ.

"There are a vast number of websites where patients can obtain cancer information," study leader Dr. Yaacov Lawrence, adjunct assistant professor of radiation oncology at Jefferson Medical College of Thomas Jefferson University, and director of the Center for Translational Research in Radiation Oncology at the Sheba Medical Center in Israel, said in a university news release. Read more...

Ayurtox for Body Detoxification

Source:
http://feeds.feedburner.com/integratedmedicine

To Read More: Wikipedia Accurate on Cancer Facts, But Hard to Read: Study
categoriaIntegrative Medicine commentoComments Off on Wikipedia Accurate on Cancer Facts, But Hard to Read: Study | dataOctober 2nd, 2011
Read All

Representative Brian Bilbray Meets with International Stem Cell Executives to Discuss Research Funding

By Dr. Matthew Watson

International Stem Cell Corporation (OTCBB: ISCO) today announced that Representative Brian Bilbray recently met with Company executives, including Chairman Kenneth Aldrich, President and Chief Executive Officer Andrey Semechkin, and Senior Vice President Kurt May, to discuss key federal government issues relating to stem cell research. Rep. Bilbray represents California's 50th congressional district, which includes portions of San Diego's North County.
Following the meeting, Rep. Bilbray stated, "I have tremendous respect for the innovative healthcare companies in my district, such as International Stem Cell, that are at the forefront of developing important new treatments and therapies. I'm committed to helping remove unnecessary regulations and barriers that may inhibit the research of new life science technologies, and I greatly appreciate the efforts of ISCO's management team to clarify many of the issues surrounding their work."
Said Dr. Semechkin, "We are very pleased to have the opportunity to meet with Congressman Bilbray and explain the importance of our parthenogenesis technology and how it differs from human embryonic stem cell development, particularly from an ethical standpoint. We look forward to continued discussions with Congressman Bilbray and his colleagues regarding the Dickey-Wicker Amendment. We believe that with increased understanding of our technology the National Institutes of Health (NIH) will support parthenogenesis research and development."
About International Stem Cell Corporation
International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. ISCO's core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs). hpSCs avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell™. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care. More information is available at http://www.internationalstemcell.com.
To subscribe to receive ongoing corporate communications, please click on the following link: http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0.
Forward-looking Statements
Statements pertaining to anticipated developments, and other opportunities for the company and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will," "believes," "plans," "anticipates," "expects," "estimates,") should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products and the management of collaborations, regulatory approvals, need and ability to obtain future capital, application of capital resources among competing uses, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the company's business, particularly those mentioned in the cautionary statements found in the company's Securities and Exchange Commission filings. The company disclaims any intent or obligation to update forward-looking statements.

International Stem Cell Corporation
Kenneth C. Aldrich, Chairman
760-940-6383
or
Lippert/Heilshorn & Associates
Don Markley
310-691-7100

dmarkley@lhai.com

Source:
http://intlstemcell.blogspot.com/feeds/posts/default?alt=rss

To Read More: Representative Brian Bilbray Meets with International Stem Cell Executives to Discuss Research Funding
categoriaStem Cell Therapy commentoComments Off on Representative Brian Bilbray Meets with International Stem Cell Executives to Discuss Research Funding | dataOctober 2nd, 2011
Read All

Repairing Damaged Hearts with Stem Cells

By Dr. Matthew Watson

Biomedical Engineering researchers at WPI are creating new, engineered heart muscle tissue from adult stem cells. Their groundbreaking discoveries could lead to the repair of damaged hearts in some patients.

Excerpt from:
Repairing Damaged Hearts with Stem Cells

To Read More: Repairing Damaged Hearts with Stem Cells
categoriaCardiac Stem Cells commentoComments Off on Repairing Damaged Hearts with Stem Cells | dataSeptember 29th, 2011
Read All

Spinal Cord Injury – Embryonic Stem Cells – Dr. Keirstead

By Dr. Matthew Watson

Spinal Cord Injury - Embryonic Stem Cells - Dr. Hans Keirstead

View original post here:
Spinal Cord Injury - Embryonic Stem Cells - Dr. Keirstead

To Read More: Spinal Cord Injury – Embryonic Stem Cells – Dr. Keirstead
categoriaSpinal Cord Stem Cells commentoComments Off on Spinal Cord Injury – Embryonic Stem Cells – Dr. Keirstead | dataSeptember 26th, 2011
Read All

Healthy Living Can Cut Chances of Developing Diabetes

By Dr. Matthew Watson

(HealthDay News) -- Living a healthy lifestyle can cut your risk of diabetes by as much as 80 percent, researchers from the U.S. National Institutes of Health report.

It has been clear that diet, exercise, smoking and drinking have an impact on whether one is likely to develop type 2 diabetes, but how each individual factor affects the risk had been unclear.

"The lifestyle factors we looked at were physical activity, healthy diet, body weight, alcohol consumption and smoking," said lead researcher Jarad Reis, a researcher from the U.S. Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute.

"For each one of those, there was a significant reduction in risk for developing diabetes," he said. "Having a normal weight by itself reduced the risk of developing diabetes by 60 to 70 percent."

For example, eating a healthy diet reduced the risk by about 15 percent, while not smoking lowered the risk by about 20 percent, he said.

The more healthy lifestyle factors one has, the lower the risk for developing diabetes, Reis noted. Overall, risk reduction can reach 80 percent, he said. Read more...

Immunice for Immune Support

Source:
http://feeds.feedburner.com/integratedmedicine

To Read More: Healthy Living Can Cut Chances of Developing Diabetes
categoriaIntegrative Medicine commentoComments Off on Healthy Living Can Cut Chances of Developing Diabetes | dataSeptember 25th, 2011
Read All

Cell Therapy & Regenerative Medicine Domains Available

By Dr. Matthew Watson

Tweet 


Please pardon the crass commercial nature of this post.  I try to keep self-promotion to a minimum here but I'm looking to unload a number of domains I have the related to cell therapy and regenerative medicine and thought this might be the easiest way to get the word out.  Let me know if you are interested in any of the following: 


anticyte.com*
biocellutions.com***
.
cardiacregenerativemedicine.com* 
cardiacregenmed.com* 
cardiactissuerepair.com* 
.
cellexpertsolutions.com**
.
celltherapyalliance.com* 
celltherapyassays.com*** 
celltherapycellutions.com**** 
celltherapycompany.com**** 
celltherapyconsortium.com* 
celltherapydevelopment.com***
celltherapymanufacturing.com**** 
celltherapymarketing.com* 
celltherapypartner.com* 
celltherapypatents.com**** 
celltherapysolution.com*** 
celltherapystrategies.com*** 
celltherapysupport.com* 
celltheraytech.com** 
celltherapytechnologies.com*** 
celltherapyventures.com*** 
celltherapyworks.com***
.
cellutionstrategies.com*** 
.
commerciaizingcelltherapy.com** 
commercialisingcelltherapy.com* 
commercializingcelltherapies.com** 
commercialisingcelltherapies.com* 
.
cordbloodshipper.com*** 
cordbloodshipping.com*** 
.
developingcelltherapies.com* 
.
diagnostacell.com* 
diagnostacells.com* 
diagnosticstemcells.com** 
.
discoverystemcells.com** 
.
expertcellutions.com***
.
integratedcelltherapycellutions.com** 
integratedcelltherapysolutions.com**
.
ipsbiologics.com** 
ipsbiomedical.com**
ipsbioscience.com**
ipsbiosystems.com**
ipsbiotechnologies.com** 
ipslifesciences.com**
.
longtailbiomedical.com***
longtailtherapeutics.com*** 
longtailtherapies.com*** 
.
personalizedcelltherapy.com*** 
.
regenerativecellutions.com*** 
regenerativemedicinepatents.com****
.
stemostics.com** 
stemomics.com** 
stemonics.com*** 
.
stemcellcollect.com*** 
.
strategiccellutions.com** 
strategicell.com*** 
.
thecelltherapycompany.com****
.
totalcelltherapysolution.com***
totalcelltherapysolutions.com*** 


Funky ones: 
 cellenterprise.com* 
 cellsforce.com* 
 cellsinnovations.com* 
 cellsmarket.com* 
 cellspitch.com*
 cellsrep.com* 
 cellstech.com* 
 cellsventure.com*
 iregener8.com** 


I have others - some of which are variations of ones listed above (such as with "the" in front) and would be available - some of which I'm still wanting to hold.
 _____________________________ 


 * ~$1,500 
** ~$5,000 
*** ~$10,000
**** ~$20,000

Source:
http://feeds.feedburner.com/CellTherapyBlog

To Read More: Cell Therapy & Regenerative Medicine Domains Available
categoriaRegenerative Medicine commentoComments Off on Cell Therapy & Regenerative Medicine Domains Available | dataSeptember 25th, 2011
Read All

Page 275«..1020..274275276277..280290..»


Copyright :: 2025